Mark Little

19PUBLICATIONS
70CO-AUTHORS
PharmacogenomicsRespiratory diseasesHuman impacts of climate change and human adaptationMolecular targetsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 25, 2026
Real-world safety assessment of avacopan in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Xiang-Yu Han, Zhi-Ying Li, Su-Fang Chen

|Oct 14, 2024
Autoantibodies towards HFE and SYT5 in anti-neutrophil cytoplasm antibody-associated vasculitis relapse.

Shaghayegh Bayati, Jamsheela Nazeer, James Ng

|Oct 04, 2024
Enabling data linkages for rare diseases in a resilient environment with the SERDIF framework.

Albert Navarro-Gallinad, Fabrizio Orlandi, Jennifer Scott

|Jun 05, 2024
FTY720 ameliorates experimental MPO-ANCA-associated vasculitis by regulating fatty acid oxidation via the neutrophil PPARα-CPT1a pathway.

Rui-Xue Wang, Luo-Yi Wang, Xiang-Yu Han

|May 25, 2024
Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and Vaccination.

Emma J Leacy, Jia Wei Teh, Aoife M O'Rourke

|Apr 30, 2024
Computable phenotype for real-world, data-driven retrospective identification of relapse in ANCA-associated vasculitis.

Jennifer Scott, Arthur White, Cathal Walsh

Pageof 4

Frequent Collaborators

4 joint publications

Jennifer Scott

3 joint publications

Zhi-Ying Li

2 joint publications

Emma Leacy

2 joint publications

Lucy Hederman